Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease.
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i


Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease.
  • Published Date:

    1999 Nov-Dec

  • Source:
    Emerg Infect Dis. 5(6):828-831.
  • Language:
    English
Filetype[PDF-94.74 KB]


Details:
No Related Documents.

You May Also Like:

  1. Personal Author:
    Rodenburg, Gerwin D. ; de Greeff, Sabine C. ; ...
    Published Date:
    May 2010
    Source:
    Emerg Infect Dis. 16(5):816-823.
    Description:
    In the Netherlands, the 7-valent pneumococcal conjugate vaccine (PCV-7) was implemented in a 3+1-dose schedule in the national immunization program fo...
    File Type:
    Filetype[PDF - 271.87 KB]
    File Type:
    Filetype[PDF - 271.87 KB]
  2. Personal Author:
    Vela Coral, María Claudia ; Fonseca, Nacxiry ; ...
    Published Date:
    2001 Sep-Oct
    Source:
    Emerg Infect Dis. 7(5):832-836.
    Description:
    Pneumococcal surface protein A (PspA) elicits protection in mice against fatal bacteremia and sepsis caused by genetically diverse pneumococci and pro...
    File Type:
    Filetype[PDF - 29.12 KB]
    File Type:
    Filetype[PDF - 29.12 KB]
  3. Personal Author:
    Nuorti, J. Pekka ; Whitney, Cynthia G. ;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) ; ...
    Published Date:
    December 10, 2010
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 59, no. RR-11
    Description:
    "On February 24, 2010, a 13-valent pneumococcal polysaccharide-protein conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals Inc., marketed by P...
    Status:
    current
    File Type:
    Filetype[PDF - 569.96 KB]
    File Type:
    Filetype[PDF - 569.96 KB]
  4. Personal Author:
    Lipsitch, M.
    Published Date:
    1999 May-Jun
    Source:
    Emerg Infect Dis. 5(3):336-345.
    Description:
    Conjugate vaccines have reduced the incidence of invasive disease caused by Haemophilus influenzae, type b (Hib), in industrialized countries and may ...
    File Type:
    Filetype[PDF - 198.75 KB]
    File Type:
    Filetype[PDF - 198.75 KB]
  5. Personal Author:
    Verani, Jennifer R. ; Santos Domingues, Carla Magda A. ; ...
    Corporate Authors:
    Brazilian Pneumococcal Conjugate Vaccine Effectiveness Study Group
    Published Date:
    October 24 2015
    Source:
    Vaccine. 33(46):6145-6148
    Description:
    We applied the indirect cohort method to estimate effectiveness of 10-valent pneumococcal conjugate vaccine (PCV10) among young children in Brazil. Ca...
    File Type:
    Filetype[PDF - 209.94 KB]
    File Type:
    Filetype[PDF - 209.94 KB]